What is your preferred grocery checkout bagging option?

Stock price movements

FILE - In this Aug. 23, 2019, file photo pedestrians pass the New York Stock Exchange in New York. The U.S. stock market opens at 9:30 a.m. EDT on Wednesday, Sept. 11. (AP Photo/Frank Franklin II, File)
September 11, 2019 - 3:59 pm

US stocks notch solid gains as China eases trade tensions

Stocks notched broad gains on Wall Street Wednesday as investors drew encouragement from China's move to exempt some U.S. products from a recent round of tariffs. Technology, health care and communication services stocks powered much of the rally. The benchmark S&P 500 index, which had been...
Read More
People stand near an electronic stock board showing Japan's Nikkei 225 index at a securities firm in Tokyo Tuesday, Sept. 10, 2019. Asian shares were mixed Tuesday after a day of listless trading on Wall Street, as investors awaited signs on global interest rates.(AP Photo/Eugene Hoshiko)
September 10, 2019 - 3:29 am

Global shares mixed as investors look to rate decisions

TOKYO (AP) — Global shares were mixed Tuesday after a day of listless trading on Wall Street, as investors awaited signs on global interest rates. France's CAC 40 slipped 0.3% to 5,569.68 in early trading, while Germany's DAX fell 0.3% to 12,193.09. Britain's FTSE 100 inched down 0.1% to 7,228.18...
Read More
FILE - In this Nov. 6, 2007, file photo Patrick Byrne, President and CEO of Overstock.com is reflected on a large television screen while being interviewed at the headquarters for supporters of school vouchers in Salt Lake City. Byrne has resigned, saying he’d become “far too controversial” to helm the e-commerce company known for selling discounted sofas and jewelry. Bryne, who founded the online discount retailer 20 years ago, said Thursday, Aug. 22, 2019, that was “in the sad position” of having to step down. (AP Photo/Steve C. Wilson)
August 22, 2019 - 4:14 pm

Overstock CEO resigns after 'Deep State' comments roil stock

SAN FRANCISCO (AP) — The CEO of Overstock.com has resigned, saying he'd become "far too controversial" to helm the e-commerce company known for selling discounted sofas and jewelry. Patrick Byrne's resignation Thursday came after the company issued a bizarre statement last week in which the former...
Read More
August 20, 2019 - 8:18 am

Elanco becomes 2nd largest animal health co after $7.6B deal

INDIANAPOLIS (AP) — Elanco Animal Health will spend $7.6 billion to acquire Bayer AG's veterinary medicines business, which would make it the second-largest animal health company. Elanco said Tuesday that it will pay $5.3 billion, or about 70% of the total price, in cash and the rest in stock. The...
Read More
August 14, 2019 - 5:26 pm

Warren Buffett's firm adds to its Amazon, bank investments

OMAHA, Neb. (AP) — Billionaire Warren Buffett's company has been adding more Amazon shares to its investment cart. Berkshire Hathaway said in filings with the Securities and Exchange Commission on Wednesday that it owned 537,300 Amazon shares at the end of June, up from 483,300 shares. Buffett...
Read More
FILE - This March 29, 2019, file photo shows a sign for Lyft in Los Angeles. Lyft is reporting strong revenue growth but deep losses in its second quarter, a trend that it has so far been unable to reverse. The ride-hailing company on Wednesday, Aug. 7, posted revenue of $867.3 million, up 72% from the same time last year. (AP Photo/Ringo H.W. Chiu, File)
August 07, 2019 - 5:40 pm

Lyft posts losses despite revenue growth, improves outlook

NEW YORK (AP) — Lyft continued to bleed money in its second quarter but says it expects to stem some of those losses, raising its outlook for 2019. The ride-hailing company on Wednesday posted revenue of $867.3 million, up 72% from the same time last year. But the San Francisco-based company lost $...
Read More
FILE - In this Sept. 21, 2016, file photo EpiPens that Mylan CEO Heather Bresch bought with her are seen on Capitol Hill in Washington as she testifies before the House Oversight Committee hearing on EpiPen price increases. Pfizer, the country's largest drugmaker, will absorb the generic pharmaceutical company Mylan, potentially creating a global generic powerhouse, the two companies said Monday, July 29, 2019. (AP Photo/Pablo Martinez Monsivais, File)
July 29, 2019 - 9:49 am

Pfizer, Mylan strengthen ties, create new company

Pfizer, the country's largest drugmaker, is creating a hybrid new drug company by combining its off-patent branded drug business with the generic pharmaceutical company Mylan. The two companies said Monday that they'll ultimately spin off the combination of Mylan, a $10 billion company, with Pfizer...
Read More
FILE - This combination of April 30, 2018, file photos shows signage for a Sprint store in New York's Herald Square, top, and signage at a T-Mobile store in New York U.S. regulators are approving T-Mobile's $26.5 billion takeover of rival Sprint, despite fears of higher prices and job cuts. (AP Photo/Bebeto Matthews, File)
July 26, 2019 - 2:10 pm

T-Mobile's $26.5B Sprint deal OKed despite competition fears

WASHINGTON (AP) — U.S. regulators have approved T-Mobile's $26.5 billion takeover of rival Sprint, despite fears of higher prices and job cuts, in a deal that would leave just three major cellphone companies in the country. Friday's approval from the Justice Department and five state attorneys...
Read More
July 09, 2019 - 3:05 am

Germany's BASF warns on profits amid weak auto sector, trade

BERLIN (AP) — Shares in Germany-based chemicals maker BASF have dropped after the company issued a profit warning, citing factors that included declining global auto production, weakness in the North American agricultural sector and trade conflicts. BASF shares dropped 5.1% to 59.38 euros ($66.62)...
Read More
In this June 5, 2009, photo a woman has Botox injected at Reveal in Arlington, Va. AbbVie is buying Botox maker Allergan in a cash-and-stock deal the drugmakers value at around $63 billion. The maker of the blockbuster immune disorder treatment Humira said Tuesday, June 25, 2019, that it will pay $120.30 in cash and a portion of AbbVie stock for each Allergan share. (AP Photo/Jacquelyn Martin, File)
June 25, 2019 - 1:39 pm

AbbVie makes $63B bid for Botox maker Allergan

Facing competition for the world's top-selling drug, AbbVie is jumping on this year's pharmaceutical merger bandwagon with a $63 billion bid for Botox maker Allergan that's meant to spur future growth. Specialty drugmaker AbbVie said Tuesday that adding Allergan's aesthetics products and eye care...
Read More

Pages